Deka Bank Deutsche Girozentrale Bio N Tech Se Transaction History
Deka Bank Deutsche Girozentrale
- $56.1 Billion
- Q2 2025
A detailed history of Deka Bank Deutsche Girozentrale transactions in Bio N Tech Se stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 481,397 shares of BNTX stock, worth $53.4 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
481,397
Previous 411,897
16.87%
Holding current value
$53.4 Million
Previous $36.6 Million
41.35%
% of portfolio
0.09%
Previous 0.07%
Shares
22 transactions
Others Institutions Holding BNTX
# of Institutions
335Shares Held
40.5MCall Options Held
1.58MPut Options Held
1.45M-
Baillie Gifford & CO8.04MShares$892 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$470 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$444 Million0.35% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$201 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...